# Rhythm Pharmaceuticals, Inc.: filings

RYTM · Nasdaq · CIK 1649904 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/rytm.md) · [Financials](/companies/rytm/financials.md) · [Filings](/companies/rytm/filings.md) · [Insiders](/companies/rytm/insiders.md)

## Reports and events: 172 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 375, 8-K 106, 144 73, 3 44, SC 13G/A 34, 10-Q 27, S-8 13, SC 13G 13, SCHEDULE 13G/A 13, SC 13D/A 11, DEFA14A 10, 10-K 9, 424B5 9, DEF 14A 9, 4/A 8, CORRESP 8, UPLOAD 6, ARS 4, DRS/A 4, DRSLTR 4, SC 13D 4, CT ORDER 3, EFFECT 3, S-3ASR 3, 424B4 2, D 2, DRS 2, S-1 2, S-1/A 2, S-1MEF 2, 10-Q/A 1, 424B7 1, 5 1, 8-A12B 1, 8-K/A 1, CERTNAS 1, D/A 1, DEFR14A 1, PRE 14A 1, S-3 1, SCHEDULE 13G 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-04 | 20:05 ET | [10-Q](/filings/0001628280-26-052533.md) | Quarterly report, period 2026-06-30 | 0001628280-26-052533 |
| 2026-08-04 | 11:49 ET | [8-K](/filings/0001628280-26-052170.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-052170 |
| 2026-06-25 | 20:46 ET | [8-K](/filings/0001628280-26-045569.md) | 5.07 Shareholder vote results | 0001628280-26-045569 |
| 2026-06-15 | 20:07 ET | [8-K](/filings/0001628280-26-043170.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-043170 |
| 2026-05-05 | 20:15 ET | [10-Q](/filings/0001628280-26-030549.md) | Quarterly report, period 2026-03-31 | 0001628280-26-030549 |
| 2026-05-05 | 11:48 ET | [8-K](/filings/0001628280-26-030136.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-030136 |
| 2026-04-29 | 20:09 ET | [DEF 14A](/filings/0001628280-26-028375.md) | Proxy statement, period 2026-06-24 | 0001628280-26-028375 |
| 2026-04-03 | 19:06 ET | [8-K](/filings/0001628280-26-023606.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-023606 |
| 2026-03-26 | 20:06 ET | [8-K](/filings/0001628280-26-021414.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-021414 |
| 2026-03-20 | 13:20 ET | [8-K](/filings/0001628280-26-019995.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-019995 |
| 2026-03-16 | 20:30 ET | [8-K](/filings/0001628280-26-018211.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-018211 |
| 2026-03-02 | 11:01 ET | [8-K](/filings/0001104659-26-021801.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-021801 |
| 2026-02-26 | 22:02 ET | [10-K](/filings/0001628280-26-012399.md) | Annual report, period 2025-12-31 | 0001628280-26-012399 |
| 2026-02-26 | 12:30 ET | [8-K](/filings/0001628280-26-011987.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-011987 |
| 2026-01-09 | 14:06 ET | [8-K](/filings/0001628280-26-001459.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-001459 |
| 2025-12-19 | 21:05 ET | [8-K](/filings/0001104659-25-123108.md) | 5.02 Departure or appointment of officers or directors | 0001104659-25-123108 |
| 2025-12-11 | 12:50 ET | [8-K](/filings/0001104659-25-120141.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-120141 |
| 2025-11-07 | 13:09 ET | [8-K](/filings/0001104659-25-108154.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-108154 |
| 2025-11-04 | 21:06 ET | [10-Q](/filings/0001104659-25-106264.md) | Quarterly report, period 2025-09-30 | 0001104659-25-106264 |
| 2025-11-04 | 12:05 ET | [8-K](/filings/0001104659-25-105904.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-105904 |
| 2025-08-05 | 20:19 ET | [10-Q](/filings/0001558370-25-010302.md) | Quarterly report, period 2025-06-30 | 0001558370-25-010302 |
| 2025-08-05 | 11:05 ET | [8-K](/filings/0001558370-25-010176.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-25-010176 |
| 2025-07-11 | 11:00 ET | [8-K](/filings/0001104659-25-067133.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-067133 |
| 2025-07-09 | 20:39 ET | [8-K](/filings/0001104659-25-066724.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-066724 |
| 2025-06-26 | 20:55 ET | [8-K](/filings/0001558370-25-008924.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001558370-25-008924 |
| 2025-05-07 | 20:46 ET | [10-Q](/filings/0001558370-25-006765.md) | Quarterly report, period 2025-03-31 | 0001558370-25-006765 |
| 2025-05-07 | 11:01 ET | [8-K](/filings/0001558370-25-006602.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-25-006602 |
| 2025-04-29 | 20:01 ET | [DEF 14A](/filings/0001558370-25-005818.md) | Proxy statement, period 2025-06-24 | 0001558370-25-005818 |
| 2025-04-07 | 11:01 ET | [8-K](/filings/0001558370-25-004507.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-25-004507 |
| 2025-03-20 | 20:05 ET | [8-K](/filings/0001558370-25-003374.md) | 1.02 Termination of a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-25-003374 |
| 2025-02-28 | 13:21 ET | [8-K](/filings/0001558370-25-001891.md) | 8.01 Other events | 0001558370-25-001891 |
| 2025-02-28 | 13:19 ET | [10-K](/filings/0001558370-25-001889.md) | Annual report, period 2024-12-31 | 0001558370-25-001889 |
| 2025-02-26 | 12:02 ET | [8-K](/filings/0001558370-25-001553.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-25-001553 |
| 2025-01-10 | 12:17 ET | [8-K](/filings/0001558370-25-000093.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-25-000093 |
| 2024-11-06 | 13:20 ET | [10-Q](/filings/0001558370-24-014532.md) | Quarterly report, period 2024-09-30 | 0001558370-24-014532 |
| 2024-11-05 | 21:02 ET | [8-K](/filings/0001104659-24-114304.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-114304 |
| 2024-09-19 | 20:49 ET | [8-K](/filings/0001104659-24-101393.md) | 5.07 Shareholder vote results | 0001104659-24-101393 |
| 2024-08-14 | 20:06 ET | [10-Q/A](/filings/0001410578-24-001438.md) | Quarterly report, amended, period 2024-06-30 | 0001410578-24-001438 |
| 2024-08-06 | 20:21 ET | [10-Q](/filings/0001558370-24-011101.md) | Quarterly report, period 2024-06-30 | 0001558370-24-011101 |
| 2024-08-06 | 11:00 ET | [8-K](/filings/0001104659-24-086081.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-086081 |
| 2024-07-10 | 20:07 ET | [8-K](/filings/0001104659-24-078941.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-078941 |
| 2024-06-17 | 21:19 ET | [8-K](/filings/0001104659-24-072376.md) | 8.01 Other events | 0001104659-24-072376 |
| 2024-05-07 | 20:43 ET | [10-Q](/filings/0001558370-24-007076.md) | Quarterly report, period 2024-03-31 | 0001558370-24-007076 |
| 2024-05-07 | 11:10 ET | [8-K](/filings/0001104659-24-057691.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-057691 |
| 2024-04-30 | 23:31 ET | [SC 13D/A](/filings/0001072613-24-000413.md) | Ownership report, active investor, amended | 0001072613-24-000413 |
| 2024-04-26 | 20:05 ET | [DEF 14A](/filings/0001104659-24-052915.md) | Proxy statement, period 2024-06-18 | 0001104659-24-052915 |
| 2024-04-17 | 20:15 ET | [SC 13D/A](/filings/0001193125-24-099106.md) | Ownership report, active investor, amended | 0001193125-24-099106 |
| 2024-04-16 | 11:00 ET | [8-K](/filings/0001104659-24-047492.md) | 1.01 Entry into a material agreement; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-047492 |
| 2024-04-03 | 22:18 ET | [SC 13D/A](/filings/0001193125-24-086172.md) | Ownership report, active investor, amended | 0001193125-24-086172 |
| 2024-04-01 | 21:25 ET | [8-K](/filings/0001104659-24-041970.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-041970 |

Page 1 of 4. [Older](/companies/rytm/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:14 ET. No prices; not investment advice.